Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Boston MA, Westbury NY, New York NY, Sellersville PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase 3, Recruiting

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

for
Cigarette Smoking-Related Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04604509

Recruiting

Study of Lung Proteins in Patients With Pneumonia

for
Pneumonia, Pulmonary Disease, Lung Disease
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 3 - 70+

Code: NCT00077909

Recruiting

Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment

for
Non-Small Cell Lung Cancer
Location: Toronto, London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 18+

Code: NCT04852588

Recruiting

Beat Childhood Cancer Specimen Banking and Data Registry

for
Pediatric Cancer, Survivorship
Location: Hartford CT, Norfolk VA, Hershey PA, Miami FL,
Sponsor: Giselle Sholler

Sex: All

Age: 0+

Code: NCT04715178

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

First In Human Study of CX-2051 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, The Bronx NY, Fairfax VA, Huntersville NC,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06265688

Phase 1, Recruiting

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

for
Solid Tumor
Location: Providence RI, Philadelphia PA, Fairfax VA,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18+

Code: NCT05907980

Phase 1, Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Westbrook ME, Mississauga, Brampton, Jacksonville FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase 3, Recruiting

The IMPACT Implementation-Effectiveness Trial

for
Cancer
Location: St. Catharines, Burlington, Hamilton
Sponsor: McMaster University

Sex: All

Age: 18+

Code: NCT06323707

Phase 2, Recruiting

Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04557709

Recruiting

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: San Antonio TX
Sponsor: TiumBio Co., Ltd.

Sex: All

Age: 18+

Code: NCT05204862

Phase 1, Phase 2, Recruiting

Response to Influenza Vaccination in Pediatric Oncology Patients

for
Hematologic Malignancy, Pediatric Cancer,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 18

Code: NCT05384288

Recruiting

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

for
Neoplasms
Location: New York NY, Montreal, Toronto, Pittsburgh PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT06311578

Phase 1, Recruiting

Sample Collection and Tracking for the Developmental Therapeutics Clinic

for
Neoplasms, Lymphoma
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03269578

Recruiting

Making Healthy Habits Stick

for
Cancer, Physical Activity, Cancer Survivor, Cancer Survivorship
Location: Birmingham AL, Memphis TN
Sponsor: University of Tennessee

Sex: Female

Age: 19+

Code: NCT06745180

Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Toronto, Ann Arbor MI, Houston TX, Dallas TX,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05941507

Phase 1, Phase 2, Recruiting

Training Nurses in Basic Hypnoanalgesia Techniques

for
Cancer
Location: Montreal
Sponsor: St. Justine's Hospital

Sex: All

Age: 5 - 18

Code: NCT02421562

Recruiting

Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors

for
Cancer
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06475807

Recruiting

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

for
Malignant Neoplasm of Bone and Articular Cartilage,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12 - 50

Code: NCT03093909

Phase 1, Recruiting

Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors

for
Solid Tumor, Adult, Oncology
Location: Huntersville NC, Santa Monica CA
Sponsor: Trethera

Sex: All

Age: 18+

Code: NCT05055609

Phase 1, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial